Related Experiment Video
Updated: Apr 16, 2026

11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
14.5K
[Natural human IFNβ and ribavirin combination therapy]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 14, 2015
Summary
Hepatitis C treatment with interferon beta (IFNβ) and ribavirin offers an effective option with fewer side effects, especially for elderly patients. This combination therapy improves sustained virological response rates in chronic hepatitis C virus (HCV) infection.
Area of Science:
- Hepatology and Virology
- Immunology
- Pharmacology
Context:
- Chronic hepatitis C virus (HCV) infection can lead to severe liver damage, including cirrhosis, liver failure, and hepatocellular carcinoma.
- Current combination therapies, including interferons (IFNs) and ribavirin or direct-acting antiviral agents (DAAs), aim to eradicate HCV and improve liver fibrosis.
- However, these treatments can cause significant adverse effects, particularly in elderly populations.
Purpose:
- To evaluate the efficacy and tolerability of natural human interferon beta (IFNβ) and ribavirin combination therapy for chronic hepatitis C.
- To compare the side effect profile of IFNβ and ribavirin with other interferon-based therapies, such as Peg-IFNα and ribavirin.
Summary:
- Interferon beta (IFNβ) and ribavirin combination therapy is an available treatment option in Japan for chronic hepatitis C.
- This combination demonstrates a lower incidence of adverse effects compared to Peg-IFNα and ribavirin treatments.
- The therapy is particularly noted for its well-tolerated profile, especially in the context of treating elderly patients.
Impact:
- IFNβ and ribavirin combination therapy represents a well-tolerated and effective treatment strategy for chronic hepatitis C.
- This approach may offer a safer alternative for patients, including the elderly, who experience significant side effects with other regimens.
- Clinicians should consider this combination as a viable option for improving sustained virological response (SVR) rates in chronic HCV infection.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
37
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
37
RNA Interference
28.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.9K
RNA Interference
7.9K
7.9K
Retroviruses
16.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
16.2K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
629
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
629
Cytomegalovirus Disease
62
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
62

